The estimated Net Worth of Gregory Dinoia is at least $1.74 Milion dollars as of 17 June 2022. Mr Dinoia owns over 555 units of Mesa Laboratories stock worth over $434,517 and over the last 5 years he sold MLAB stock worth over $941,884. In addition, he makes $361,139 as Sr. VP of Commercial Operations at Mesa Laboratories.
Sign up
Mr DiNoia MLAB stock SEC Form 4 insiders trading
Mr has made over 11 trades of the Mesa Laboratories stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 555 units of MLAB stock worth $104,462 on 17 June 2022.
The largest trade he's ever made was selling 1,211 units of Mesa Laboratories stock on 15 June 2021 worth over $309,616. On average, Mr trades about 389 units every 78 days since 2019. As of 17 June 2022 he still owns at least 3,634 units of Mesa Laboratories stock.
You can see the complete history of Mr Dinoia stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Gregory T. DiNoia biography
Gregory T. DiNoia is the Sr. VP of Commercial Operations at Mesa Laboratories.
What is the salary of Mr DiNoia?
As the Sr. VP of Commercial Operations of Mesa Laboratories, the total compensation of Mr DiNoia at Mesa Laboratories is $361,139. There are 7 executives at Mesa Laboratories getting paid more, with Gary Owens having the highest compensation of $3,485,970.
How old is Mr DiNoia?
Mr DiNoia is 56, he's been the Sr. VP of Commercial Operations of Mesa Laboratories since . There are 3 older and 11 younger executives at Mesa Laboratories. The oldest executive at Mesa Laboratories, Inc. is David Kelly, 78, who is the Independent Director.
What's Mr DiNoia's mailing address?
Gregory's mailing address filed with the SEC is West 6th Avenue Frontage Road, Lakewood, Jefferson County, Colorado, 80225, United States.
Insiders trading at Mesa Laboratories
Over the last 21 years, insiders at Mesa Laboratories have traded over $50,273,983 worth of Mesa Laboratories stock and bought 209,660 units worth $5,099,819 . The most active insiders traders include Mark Christopher Capone, R Tony Tripeny a John James Sullivan. On average, Mesa Laboratories executives and independent directors trade stock every 20 days with the average trade being worth of $430,930. The most recent stock trade was executed by Gary M Owens on 6 September 2024, trading 3,301 units of MLAB stock currently worth $394,701.
What does Mesa Laboratories do?
mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers
What does Mesa Laboratories's logo look like?
Complete history of Mr Dinoia stock trades at Mesa Laboratories
Mesa Laboratories executives and stock owners
Mesa Laboratories executives and other stock owners filed with the SEC include:
-
Gary Owens,
President, Chief Executive Officer, Director -
John Sakys,
Chief Financial Officer, Executive Vice President, Chief Accounting Officer, Corporate Secretary -
Greg DiNoia,
Senior Vice President - Commercial Operations -
Gary M. Owens,
CEO, Pres & Director -
Brian Archbold,
Senior Vice President - Continuous Improvement -
Brian David Archbold,
Sr. VP of Continuous Improvement -
John V. Sakys,
CFO & Chief Accounting Officer -
Gregory T. DiNoia,
Sr. VP of Commercial Operations -
John Sullivan,
Chairman of the Board -
John Schmieder,
Independent Director -
David Kelly,
Independent Director -
Evan Guillemin,
Independent Director -
Jennifer Alltoft,
Independent Director -
Shannon Hall,
Director -
Peter M. Dansky,
Pres of Clinical Genomics -
Garrett Krushefski,
Sr. VP of Operations -
Bryan T. Leo,
Sr. VP of Operations -
Gina Hinman Trulli,
VP of HR -
Elizabeth Karpinski Vonne,
VP of Legal, Gen. Counsel & Sec. -
Robert Bradley,
Sr. Director of Operations -
Michael T Brooks,
Director -
H Stuart Campbell,
Director -
Ventures, Llc Seg,
Director -
Luke R Schmieder,
President CEO Treasurer -
Paul D Duke,
Director -
Michael Tranmer,
Executive Vice President -
Glenn E Adriance,
VP Sales and Marketing -
Steven W Peterson,
VP Finance, CFO, Secretary -
Robert V Dwyer,
Director -
David Brian Perez,
Director -
Mark Christopher Capone,
Director -
Shiraz Shabanali Ladiwala,
Director -
Laboratories Inc /Co/ Mesa,
Director -
R Tony Tripeny,
Director